Earnings
Home›Earnings›Previews›GLP-1 demand boosts cold-chain logistics outlook for m…
GLP-1 demand boosts cold-chain logistics outlook for major carriers
Industry coverage highlights healthcare transportation as an expanding revenue driver, with several logistics firms tied to GLP-1 driven cold-chain growth and infrastructure spending.
GLP-1 drug demand is creating a new growth and dividend angle for logistics companies focused on cold-chain transportation, according to MarketBeat Ratings.
The outlet points to GLP-1 related demand as a tailwind for cold-chain logistics expansion at FedEx, UPS, DHL Group, and C.H. Robinson, which are each pursuing healthcare transportation revenue growth.
MarketBeat Ratings says the theme extends beyond existing shipments, with companies expanding logistics infrastructure intended to support the needs of healthcare transportation.